Overview
Dr. Kendall Moseley is the Clinical Director of the Division of Diabetes, Endocrinology & Metabolism, Medical Director of the Johns Hopkins Metabolic Bone & Osteoporosis Center and Co-Director of the Johns Hopkins Multidisciplinary Parathyroid Clinic. Dr. Moseley received her medical degree from Baylor College of Medicine in Houston, TX, followed by internal medicine residency training at the Johns Hopkins Hospital. Upon completion of her endocrinology fellowship at Johns Hopkins, she joined the faculty in the Division of Endocrinology, Diabetes & Metabolism of the Johns Hopkins University School of Medicine. Dr. Moseley has a dynamic clinical practice and collaborations within the institution that focus on metabolic bone diseases, osteoporosis, hyperparathyroidism, vitamin D deficiency, atypical fractures, and skeletal survivorship. She is actively engaged in NIH-funded clinical and translational research involving the relationship between type 2 diabetes, osteoporosis, and aging. She is additionally involved in research investigating mechanisms by which chronic disease states such as malignancy, HIV, hepatitis C, and cystic fibrosis impact bone quantity and quality. Clinically, she enjoys partnering with her patients and using their unique and often complex medical history to individually tailor effective diet, lifestyle, and treatment regimens to improve skeletal health.
Dr. Moseley is rated as an Advanced provider by MediFind in the treatment of Hyperparathyroidism. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Paget's Disease of Bone, and Hyperparathyroidism.
Her clinical research consists of co-authoring 33 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Hyperparathyroidism.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4940 Eastern Avenue, Bayview Medical Offices, Level 1 (M), MSK, Bayview Medical Offices, Level 1 (M), MSK, Baltimore, MD 21224
Additional Areas of Focus
Dr. Moseley has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
William Simonds is an Endocrinologist in Baltimore, Maryland. Dr. Simonds is rated as an Elite provider by MediFind in the treatment of Hyperparathyroidism. His top areas of expertise are Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia, Parathyroid Adenoma, Parathyroidectomy, and Thymectomy.
Lee Weinstein is an Endocrinologist in Bethesda, Maryland. Dr. Weinstein is rated as an Elite provider by MediFind in the treatment of Hyperparathyroidism. His top areas of expertise are Multiple Endocrine Neoplasia, Multiple Endocrine Neoplasia Type 1, Albright's Hereditary Osteodystrophy, Parathyroidectomy, and Thymectomy.
University Of Maryland Physicians PA
Hilary Whitlatch is an Endocrinologist in Baltimore, Maryland. Dr. Whitlatch is rated as an Advanced provider by MediFind in the treatment of Hyperparathyroidism. Her top areas of expertise are Rabson-Mendenhall Syndrome, Hyperparathyroidism, Osteoporosis, and Postmenopausal Osteoporosis.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- OsteoporosisDr. Moseley isDistinguished. Learn about Osteoporosis.
- Paget's Disease of BoneDr. Moseley isDistinguished. Learn about Paget's Disease of Bone.
- Postmenopausal OsteoporosisDr. Moseley isDistinguished. Learn about Postmenopausal Osteoporosis.
- Advanced
- HyperparathyroidismDr. Moseley isAdvanced. Learn about Hyperparathyroidism.
- Juvenile Primary OsteoporosisDr. Moseley isAdvanced. Learn about Juvenile Primary Osteoporosis.
- Experienced
- Anaplastic Thyroid CancerDr. Moseley isExperienced. Learn about Anaplastic Thyroid Cancer.
- Autosomal Dominant HypocalcemiaDr. Moseley isExperienced. Learn about Autosomal Dominant Hypocalcemia.
- Familial Hypocalciuric Hypercalcemia Type 1
- Familial Isolated HyperparathyroidismDr. Moseley isExperienced. Learn about Familial Isolated Hyperparathyroidism.
- Follicular Thyroid CancerDr. Moseley isExperienced. Learn about Follicular Thyroid Cancer.
- Fractured SpineDr. Moseley isExperienced. Learn about Fractured Spine.